201 related articles for article (PubMed ID: 32996421)
1. A novel
Watanabe K; Nakamura T; Onodera S; Saito A; Shibahara T; Azuma T
Tumour Biol; 2020 Sep; 42(9):1010428320962588. PubMed ID: 32996421
[TBL] [Abstract][Full Text] [Related]
2. GNAS(R201H) and Kras(G12D) cooperate to promote murine pancreatic tumorigenesis recapitulating human intraductal papillary mucinous neoplasm.
Taki K; Ohmuraya M; Tanji E; Komatsu H; Hashimoto D; Semba K; Araki K; Kawaguchi Y; Baba H; Furukawa T
Oncogene; 2016 May; 35(18):2407-12. PubMed ID: 26257060
[TBL] [Abstract][Full Text] [Related]
3. A GNAS mutation found in pancreatic intraductal papillary mucinous neoplasms induces drastic alterations of gene expression profiles with upregulation of mucin genes.
Komatsu H; Tanji E; Sakata N; Aoki T; Motoi F; Naitoh T; Katayose Y; Egawa S; Unno M; Furukawa T
PLoS One; 2014; 9(2):e87875. PubMed ID: 24498386
[TBL] [Abstract][Full Text] [Related]
4. Constitutive stimulatory G protein activity in limb mesenchyme impairs bone growth.
Karaca A; Malladi VR; Zhu Y; Tafaj O; Paltrinieri E; Wu JY; He Q; Bastepe M
Bone; 2018 May; 110():230-237. PubMed ID: 29471062
[TBL] [Abstract][Full Text] [Related]
5. The activating mutation R201C in GNAS promotes intestinal tumourigenesis in Apc(Min/+) mice through activation of Wnt and ERK1/2 MAPK pathways.
Wilson CH; McIntyre RE; Arends MJ; Adams DJ
Oncogene; 2010 Aug; 29(32):4567-75. PubMed ID: 20531296
[TBL] [Abstract][Full Text] [Related]
6. Intragenic suppression of a constitutively active allele of Gsα associated with McCune-Albright syndrome.
Tobar-Rubin R; Sultan D; Janevska D; Turcic K; Carroll J; Ooms L; Pals-Rylaarsdam R
J Mol Endocrinol; 2013 Apr; 50(2):193-201. PubMed ID: 23288949
[TBL] [Abstract][Full Text] [Related]
7. Potent constitutive cyclic AMP-generating activity of XLαs implicates this imprinted GNAS product in the pathogenesis of McCune-Albright syndrome and fibrous dysplasia of bone.
Mariot V; Wu JY; Aydin C; Mantovani G; Mahon MJ; Linglart A; Bastepe M
Bone; 2011 Feb; 48(2):312-20. PubMed ID: 20887824
[TBL] [Abstract][Full Text] [Related]
8. GNAS
Ideno N; Yamaguchi H; Ghosh B; Gupta S; Okumura T; Steffen DJ; Fisher CG; Wood LD; Singhi AD; Nakamura M; Gutkind JS; Maitra A
Gastroenterology; 2018 Nov; 155(5):1593-1607.e12. PubMed ID: 30142336
[TBL] [Abstract][Full Text] [Related]
9. Detection of Rare Somatic GNAS Mutation in McCune-Albright Syndrome Using a Novel Peptide Nucleic Acid Probe in a Single Tube.
Lo FS; Chen TL; Chiou CC
Molecules; 2017 Nov; 22(11):. PubMed ID: 29104223
[TBL] [Abstract][Full Text] [Related]
10. Frequency of GNAS R201H substitution mutation in polyostotic fibrous dysplasia: Pyrosequencing analysis in tissue samples with or without decalcification.
Shin SJ; Lee SJ; Kim SK
Sci Rep; 2017 Jun; 7(1):2836. PubMed ID: 28588314
[TBL] [Abstract][Full Text] [Related]
11. Induced
Khan SK; Yadav PS; Elliott G; Hu DZ; Xu R; Yang Y
Proc Natl Acad Sci U S A; 2018 Jan; 115(3):E418-E427. PubMed ID: 29158412
[TBL] [Abstract][Full Text] [Related]
12. Activating GNAS mutations in parosteal osteosarcoma.
Carter JM; Inwards CY; Jin L; Evers B; Wenger DE; Oliveira AM; Fritchie KJ
Am J Surg Pathol; 2014 Mar; 38(3):402-9. PubMed ID: 24525511
[TBL] [Abstract][Full Text] [Related]
13. The biological basis and function of GNAS mutation in pseudomyxoma peritonei: a review.
Lin YL; Ma R; Li Y
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2179-2188. PubMed ID: 32700107
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel GNAS mutations in intramuscular myxoma using next-generation sequencing with single-molecule tagged molecular inversion probes.
Bekers EM; Eijkelenboom A; Rombout P; van Zwam P; Mol S; Ruijter E; Scheijen B; Flucke U
Diagn Pathol; 2019 Feb; 14(1):15. PubMed ID: 30736805
[TBL] [Abstract][Full Text] [Related]
15. Germline-Derived Gain-of-Function Variants of Gs
Miyado M; Fukami M; Takada S; Terao M; Nakabayashi K; Hata K; Matsubara Y; Tanaka Y; Sasaki G; Nagasaki K; Shiina M; Ogata K; Masunaga Y; Saitsu H; Ogata T
J Am Soc Nephrol; 2019 May; 30(5):877-889. PubMed ID: 30962325
[TBL] [Abstract][Full Text] [Related]
16. GNAS mutations in primary mucinous and non-mucinous lung adenocarcinomas.
Ritterhouse LL; Vivero M; Mino-Kenudson M; Sholl LM; Iafrate AJ; Nardi V; Dong F
Mod Pathol; 2017 Dec; 30(12):1720-1727. PubMed ID: 28776576
[TBL] [Abstract][Full Text] [Related]
17. Mutant GNAS limits tumor aggressiveness in established pancreatic cancer via antagonizing the KRAS-pathway.
Kawabata H; Ono Y; Tamamura N; Oyama K; Ueda J; Sato H; Takahashi K; Taniue K; Okada T; Fujibayashi S; Hayashi A; Goto T; Enomoto K; Konishi H; Fujiya M; Miyakawa K; Tanino M; Nishikawa Y; Koga D; Watanabe T; Maeda C; Karasaki H; Liss AS; Mizukami Y; Okumura T
J Gastroenterol; 2022 Mar; 57(3):208-220. PubMed ID: 35018527
[TBL] [Abstract][Full Text] [Related]
18. GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation.
Nault JC; Fabre M; Couchy G; Pilati C; Jeannot E; Tran Van Nhieu J; Saint-Paul MC; De Muret A; Redon MJ; Buffet C; Salenave S; Balabaud C; Prevot S; Labrune P; Bioulac-Sage P; Scoazec JY; Chanson P; Zucman-Rossi J
J Hepatol; 2012 Jan; 56(1):184-91. PubMed ID: 21835143
[TBL] [Abstract][Full Text] [Related]
19. GNAS transcripts in skeletal progenitors: evidence for random asymmetric allelic expression of Gs alpha.
Michienzi S; Cherman N; Holmbeck K; Funari A; Collins MT; Bianco P; Robey PG; Riminucci M
Hum Mol Genet; 2007 Aug; 16(16):1921-30. PubMed ID: 17566083
[TBL] [Abstract][Full Text] [Related]
20. Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype.
Ideno N; Ohtsuka T; Kono H; Fujiwara K; Oda Y; Aishima S; Ito T; Ishigami K; Tokunaga S; Ohuchida K; Takahata S; Nakamura M; Mizumoto K; Tanaka M
Ann Surg; 2013 Jul; 258(1):141-51. PubMed ID: 23532108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
